| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/10/2004 | CN1480465A Recombinded chemotaxis cytokine of human cirumferential lymphatic tissue as well as its preparing method and usage |
| 03/10/2004 | CN1480464A Ethane cyclic amp receptor protein of wheat and its coding sequence |
| 03/10/2004 | CN1480218A Medicinal preparation of slowly-released bioactive substance, its prepn. and application |
| 03/10/2004 | CN1480213A Effect of transfer factor and substance of small peptides restraining SARS virus fully |
| 03/10/2004 | CN1480212A Application of neurotoxin therapy in treatment of urinary system and relative diseases |
| 03/10/2004 | CN1480211A Usage of gene NMESI related to esophageal carcinoma and encoded polypeptide |
| 03/10/2004 | CN1480210A Usage of leptin for promoting healing of wound |
| 03/10/2004 | CN1141389C Method for producing recombinant glucokinase |
| 03/10/2004 | CN1141318C Human blood and blood vessel cytopoiesis hormone and its preparation |
| 03/10/2004 | CN1141317C Cyelosporin derivatives with anti-HIV effect |
| 03/10/2004 | CN1141141C Achyranthis bidentatae glycopeptide and its preparation |
| 03/10/2004 | CN1141140C Process for preparing artificially synthetic polypeptide medicines |
| 03/09/2004 | US6703493 Ob (obesity) polypeptides possess an ability to participate in the control of mammalian body weight; use in detection, monitoring, screening, and diagnosis of modulators of weight control; use in treatment/regulation of obesity in mammals |
| 03/09/2004 | US6703490 Amphiphilic complexes, method for their preparation and compositions containing them |
| 03/09/2004 | US6703489 Antibodies to vertebrate serrate proteins and fragments |
| 03/09/2004 | US6703488 Use for intracellular delivery of drugs or other agents for diagnosis and therapy of malignancies or immune-mediated or inflammatory conditions providing rapid, efficient internal-ization of the cytokine receptor antibody/antigen complexes |
| 03/09/2004 | US6703486 Peripheral nervous system specific sodium channels |
| 03/09/2004 | US6703485 Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof |
| 03/09/2004 | US6703483 Peptides and their analogs for use in management of pain during labor |
| 03/09/2004 | US6703482 Isolated from three phage-displayed random peptide libraries which had been screened for isolates that bind to bacterial fusion proteins comprising sh3 and glutathione s-transferase (gst). |
| 03/09/2004 | US6703480 Bind and activate erythropoietin receptor or otherwise act as an erythropoietin agonist |
| 03/09/2004 | US6703477 Acid end group poly(D,L-lactide-co-glycolide) copolymers with high glycolide content |
| 03/09/2004 | US6703403 Method for improving pharmacokinetics |
| 03/09/2004 | US6703381 Administering amphiphilic enkephalin-oligomer conjugate |
| 03/09/2004 | US6703377 Viscosity; biodegradability; fibroblast growth factor |
| 03/09/2004 | US6703375 Molecular chemotherapy enhancement of radiotherapy |
| 03/09/2004 | US6703368 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 03/09/2004 | US6703367 Luteinizing hormone releasing hormone (lhrh) antagonist is administered to patient in menopause |
| 03/09/2004 | US6703365 Glucagon-like insulinotropic peptides, compositions and methods |
| 03/09/2004 | US6703364 Thrombin generation inhibitors |
| 03/09/2004 | US6703363 Recombinant laminin 5 |
| 03/09/2004 | US6703362 Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods |
| 03/09/2004 | US6703361 Method of treating or preventing Type 1 diabetes by oral administration of insulin |
| 03/09/2004 | US6703360 Species-specific regions of nucleic acids that encode the heavy chain of canine immunoglobulin g and interleuken-13 receptors; regulation of immune and inflammatory responses |
| 03/09/2004 | US6703359 Treating toxic hypervolemia, renal failure, congestive heart failure, nephrotic syndrome, pulmonary edema, and hypertension |
| 03/09/2004 | US6703230 47174, a novel human glycosyltransferase and uses thereof |
| 03/09/2004 | US6703225 Having high specific activity, and a gene thereof, as well as medical uses; eg. for hepatitis and cancer |
| 03/09/2004 | US6703222 Nucleotide sequences coding low density lipoprotein for use in the treatment of viral infections |
| 03/09/2004 | US6703219 Has the same amino acid sequence as an unmutated c-reactive protein (crp) subunit except that at least one cystein has been deleted or replaced by another; used to detect cancer cells or immune complexes |
| 03/09/2004 | US6703215 Detecting preferential enzyme inhibitor; obtain substrate, incubate with enzyme mixture, expose to enzyme inhibitor, monitor for decrease in enzymatic activity |
| 03/09/2004 | US6703213 Substrate analogs for MurG, methods of making same and assays using same |
| 03/09/2004 | US6703201 Human PEC-60-like protein and DNA encoding this protein |
| 03/09/2004 | US6703198 By detecting a mutation within a jagged1 gene |
| 03/09/2004 | US6703037 Biodegradable macromers for the controlled release of biologically active substances |
| 03/09/2004 | US6703021 Composition containing α-fodrin or α-fodrin fragment protein |
| 03/09/2004 | US6703016 Apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines |
| 03/09/2004 | US6703015 Vaccination against plaque forming diseases, alzheimer's disease |
| 03/09/2004 | US6702705 Prodrugs activated by targeted catalytic proteins |
| 03/09/2004 | CA2323929C Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| 03/09/2004 | CA2322188C The use of fumaric acid derivatives in transplant medicine |
| 03/09/2004 | CA2260992C Eye treatments using synthetic thyroid hormone compositions |
| 03/09/2004 | CA2138793C Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections |
| 03/04/2004 | WO2004019036A2 Method for identifying substances |
| 03/04/2004 | WO2004018706A2 A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish |
| 03/04/2004 | WO2004018698A2 Lectin compositions and methods for modulating an immune response to an antigen |
| 03/04/2004 | WO2004018697A2 Protease resistant ti-growth hormone releasing hormone |
| 03/04/2004 | WO2004018684A2 T-cell epitopes in staphylococcal enterotoxin b |
| 03/04/2004 | WO2004018681A2 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 03/04/2004 | WO2004018680A1 Method of screening tumor antigen |
| 03/04/2004 | WO2004018678A1 Preventives/remedies for cancer |
| 03/04/2004 | WO2004018676A2 Rnai probes targeting cancer-related proteins |
| 03/04/2004 | WO2004018675A1 Treatment of melanoma by reduction in clusterin levels |
| 03/04/2004 | WO2004018670A1 Inhibitor of physiological activity of annexin 5 |
| 03/04/2004 | WO2004018669A1 Salt-inducible kinases 2 and use thereof |
| 03/04/2004 | WO2004018666A1 Expression vectors encoding epitopes of target-associated antigens |
| 03/04/2004 | WO2004018629A2 Stars-a muscle-specification-binding protein |
| 03/04/2004 | WO2004018628A2 Charged peptide-amphiphile solutions & self-assembled peptide nanofiber networks formed therefrom |
| 03/04/2004 | WO2004018624A2 Random transposon insertion in staphylococcus aureus and use thereof to identify essential genes |
| 03/04/2004 | WO2004018619A2 P53 binding t cell receptor molecules and uses thereof |
| 03/04/2004 | WO2004018615A1 Fibrin-containing composition |
| 03/04/2004 | WO2004018517A2 POLYPEPTIDE HAVING GnSAF ACTIVITY AND SYNTHETIC ANTIBODIES |
| 03/04/2004 | WO2004018515A2 T-cell epitopes in erythropoietin |
| 03/04/2004 | WO2004018512A2 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 03/04/2004 | WO2004018510A1 Marker for cancer |
| 03/04/2004 | WO2004018505A1 Akap84 and its use for visualization of biological structures |
| 03/04/2004 | WO2004018503A1 Template-fixed peptidomimetics with antibacterial activity |
| 03/04/2004 | WO2004018502A1 Compounds binding to p-selectin |
| 03/04/2004 | WO2004018499A2 Synthetic heparin-binding growth factor analogs |
| 03/04/2004 | WO2004018498A2 Minicell display and products therefrom |
| 03/04/2004 | WO2004018491A1 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 03/04/2004 | WO2004018043A1 A pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease |
| 03/04/2004 | WO2004018002A2 Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells |
| 03/04/2004 | WO2004017996A1 Arthrodial cartilage extracellular matrix degradation inhibitor |
| 03/04/2004 | WO2004017989A1 Methods for improving islet signaling in diabetes mellitus and for its prevention |
| 03/04/2004 | WO2004017988A1 Enzyme containing composition, process of producing said composition and its use |
| 03/04/2004 | WO2004017987A2 Heterocarpin, a plant-derived protein with anti-cancer properties |
| 03/04/2004 | WO2004017986A1 Growth hormone-releasing peptides in the treatment of prevention of atherosclerosis and hypercholesterolemia |
| 03/04/2004 | WO2004017985A1 Multifunctional context-activated protides and methods of use |
| 03/04/2004 | WO2004017978A1 Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy |
| 03/04/2004 | WO2004017946A1 Treating alzheimers using delipidated protein particles |
| 03/04/2004 | WO2004017923A2 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 03/04/2004 | WO2004017921A2 Method for treating inflammatory bowel disease |
| 03/04/2004 | WO2004017919A2 Use of mullerian inhibiting substance and interferon for treating tumors |
| 03/04/2004 | WO2004017916A2 Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition |
| 03/04/2004 | WO2004017912A2 Methods for increasing the rate of heart muscle contraction |
| 03/04/2004 | WO2004017902A2 Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune system |
| 03/04/2004 | WO2004017810A2 Tumor specific oligosaccharide epitopes and use thereof |
| 03/04/2004 | WO2004017727A1 A method of treatment and prophylaxis |
| 03/04/2004 | WO2004009015A3 Combination therapy for the treatment of obesity |
| 03/04/2004 | WO2004005554A3 Antisense modulation of livin expression |